This, in turn, elevated fatty acid and cholesterol biosynthetic activities, promoting hepatocellular carcinoma tumorigenesis and development through the activated mammalian target of rapamycin (mTOR) cascade [77]. Here, MTOR is linked to hepatocellular carcinoma.